222 related articles for article (PubMed ID: 15134357)
1. Proteomics to diagnose human tumors and provide prognostic information.
Ornstein DK; Petricoin EF
Oncology (Williston Park); 2004 Apr; 18(4):521-9; discussion 529-32. PubMed ID: 15134357
[TBL] [Abstract][Full Text] [Related]
2. Proteomics of breast carcinoma.
Somiari RI; Somiari S; Russell S; Shriver CD
J Chromatogr B Analyt Technol Biomed Life Sci; 2005 Feb; 815(1-2):215-25. PubMed ID: 15652811
[TBL] [Abstract][Full Text] [Related]
3. Proteomics in cancer.
Reymond MA; Schlegel W
Adv Clin Chem; 2007; 44():103-42. PubMed ID: 17682341
[TBL] [Abstract][Full Text] [Related]
4. Proteomics for the identification of new prostate cancer biomarkers.
Ornstein DK; Tyson DR
Urol Oncol; 2006; 24(3):231-6. PubMed ID: 16678055
[TBL] [Abstract][Full Text] [Related]
5. Recent advances in oncoproteomics.
Jain KK
Curr Opin Mol Ther; 2002 Jun; 4(3):203-9. PubMed ID: 12139304
[TBL] [Abstract][Full Text] [Related]
6. A serum proteomic pattern for the detection of colorectal adenocarcinoma using surface enhanced laser desorption and ionization mass spectrometry.
Liu XP; Shen J; Li ZF; Yan L; Gu J
Cancer Invest; 2006 Dec; 24(8):747-53. PubMed ID: 17162557
[TBL] [Abstract][Full Text] [Related]
7. Clinical proteomics and mass spectrometry profiling for cancer detection.
Solassol J; Jacot W; Lhermitte L; Boulle N; Maudelonde T; Mangé A
Expert Rev Proteomics; 2006 Jun; 3(3):311-20. PubMed ID: 16771703
[TBL] [Abstract][Full Text] [Related]
8. Proteomic approaches to the diagnosis, treatment, and monitoring of cancer.
Wulfkuhle JD; Paweletz CP; Steeg PS; Petricoin EF; Liotta L
Adv Exp Med Biol; 2003; 532():59-68. PubMed ID: 12908550
[TBL] [Abstract][Full Text] [Related]
9. 2D-DIGE: comparative proteomics of cellular signalling pathways.
Larbi NB; Jefferies C
Methods Mol Biol; 2009; 517():105-32. PubMed ID: 19378013
[TBL] [Abstract][Full Text] [Related]
10. [Application of laser capture microdissection and surface-enhanced laser desorption ionization time-of-flight mass spectrometry to screen biomarkers for early diagnosis of lung adenocarcinoma].
Tian YX; Yang SY; Nan YD; Zhang W; Yu JK; Zheng S
Sichuan Da Xue Xue Bao Yi Xue Ban; 2009 Jan; 40(1):157-61. PubMed ID: 19292069
[TBL] [Abstract][Full Text] [Related]
11. Proteomic approaches for serum biomarker discovery in cancer.
Maurya P; Meleady P; Dowling P; Clynes M
Anticancer Res; 2007; 27(3A):1247-55. PubMed ID: 17593616
[TBL] [Abstract][Full Text] [Related]
12. Breast cancer proteomics by laser capture microdissection, sample pooling, 54-cm IPG IEF, and differential iodine radioisotope detection.
Neubauer H; Clare SE; Kurek R; Fehm T; Wallwiener D; Sotlar K; Nordheim A; Wozny W; Schwall GP; Poznanović S; Sastri C; Hunzinger C; Stegmann W; Schrattenholz A; Cahill MA
Electrophoresis; 2006 May; 27(9):1840-52. PubMed ID: 16645950
[TBL] [Abstract][Full Text] [Related]
13. [Clinical proteomics: towards early detection of cancers].
Solassol J; Boulle N; Maudelonde T; Mangé A
Med Sci (Paris); 2005; 21(8-9):722-9. PubMed ID: 16115457
[TBL] [Abstract][Full Text] [Related]
14. Laser capture microdissection in comparative proteomic analysis of hepatocellular carcinoma.
Wang HY
Methods Cell Biol; 2007; 82():689-707. PubMed ID: 17586277
[TBL] [Abstract][Full Text] [Related]
15. Proteome analysis for the identification of tumor-associated biomarkers in gastrointestinal cancer.
Fels LM; Buschmann T; Meuer J; Reymond MA; Lamer S; Röcken C; Ebert MP
Dig Dis; 2003; 21(4):292-8. PubMed ID: 14752218
[TBL] [Abstract][Full Text] [Related]
16. Proteomic patterns: their potential for disease diagnosis.
Xiao Z; Prieto D; Conrads TP; Veenstra TD; Issaq HJ
Mol Cell Endocrinol; 2005 Jan; 230(1-2):95-106. PubMed ID: 15664456
[TBL] [Abstract][Full Text] [Related]
17. Oncoproteomics of hepatocellular carcinoma: from cancer markers' discovery to functional pathways.
Sun S; Lee NP; Poon RT; Fan ST; He QY; Lau GK; Luk JM
Liver Int; 2007 Oct; 27(8):1021-38. PubMed ID: 17845530
[TBL] [Abstract][Full Text] [Related]
18. Discovery of serum protein biomarkers for prostate cancer progression by proteomic analysis.
Al-Ruwaili JA; Larkin SE; Zeidan BA; Taylor MG; Adra CN; Aukim-Hastie CL; Townsend PA
Cancer Genomics Proteomics; 2010; 7(2):93-103. PubMed ID: 20335524
[TBL] [Abstract][Full Text] [Related]
19. SELDI-TOF serum proteomics and colorectal cancer: a current overview.
Gemoll T; Roblick UJ; Auer G; Jörnvall H; Habermann JK
Arch Physiol Biochem; 2010; 116(4-5):188-96. PubMed ID: 20615064
[TBL] [Abstract][Full Text] [Related]
20. [Clinical proteomics in laboratory medicine].
Nomura F
Rinsho Byori; 2006 Apr; 54(4):413-20. PubMed ID: 16722462
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
